Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer

Published:2019-01 Issue:1 Volume:103 Page:195-207
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Zhang Le,Bochkur Dratver Milana,Yazal Taha,Dong Kevin,Nguyen Andrea,Yu Garrett,Dao Amy,Bochkur Dratver Michael,Duhachek-Muggy Sara,Bhat Kruttika,Alli Claudia,Pajonk Frank,Vlashi Erina

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference54 articles.

1. Response to neoadjuvant therapy and long-term survival in patients with triple- negative breast cancer;Liedtke;J Clin Oncol,2008

2. Prospective identification of tumorigenic breast cancer cells;Al-Hajj;Proc Natl Acad Sci U S A,2003

3. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome;Ginestier;Cell Stem Cell,2007

4. The response of CD24(/low)/CD44+ breast cancer-initiating cells to radiation;Phillips;J Natl Cancer Inst,2006

5. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells;Woodward;Proc Natl Acad Sci U S A,2007

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo evaluation of mebendazole and Ran GTPase inhibition in breast cancer model system;Nanomedicine;2024-04-25

2. Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing;Cancers;2024-04-11

3. A novel treatment to enhance survival for end stage triple negative breast cancer using repurposed veterinary anthelmintics combined with gut‑supporting/immune enhancing molecules;Oncology Reports;2023-12-22

4. Multi-spectroscopic and molecular simulation methods of analysis to explore the mode of binding of Mebendazole drug with calf-thymus DNA;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2023-11

5. In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-10-14